---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-014872"
form_type: "8-K"
ticker: "LUCD"
cik: "0001799011"
company_name: "Lucid Diagnostics Inc."
filed_at: "2025-09-25T23:59:59+00:00"
generated_at: "2026-05-17T05:41:23.544857+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Lucid Diagnostics appoints John R. Palumbo, healthcare veteran, to board effective Sept 22, 2025

## Summary
- John R. Palumbo appointed as Class B director, effective September 22, 2025, designated by convertible note holders.
- Palumbo brings 40 years of healthcare leadership, including roles at AmerisourceBergen, Allscripts, and ValueHealth.
- He will receive cash fees and equity awards per non-employee director compensation policy.
- He currently serves on boards of PM Pediatrics, ivWatch, Qless, and chairs Brado advisory board.

## SEC filing metadata
- accession: 0001493152-25-014872
- form_type: 8-K
- ticker: LUCD
- cik: 0001799011
- company_name: Lucid Diagnostics Inc.
- filed_at: 2025-09-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799011/000149315225014872/0001493152-25-014872-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799011/000149315225014872/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-014872
- JSON: https://secwatch.observer/filing/0001493152-25-014872.json
- Plain text: https://secwatch.observer/filing/0001493152-25-014872.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.